Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02083770 · ClinicalTrials.gov registry record · Phase 3

Clinical Trials Education Program for Hispanic Americans

A Phase 3 study, sponsored by University of California, San Diego.

Completed
Registry status
Phase 3
Development phase
1,034
Enrollment target

NCT02083770: Completed Phase 3 study, sponsored by University of California, San Diego.

NCT02083770 is a Phase 3 study that has completed, run by University of California, San Diego. The registered enrollment target is 1,034 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (34% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02083770, a Phase 3 study, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
Phase 3
Development phase
1,034 participants
Enrollment target

Study Summary

Hispanic Americans are underrepresented in cancer clinical trials. The purpose of this study is to develop and test programs designed to reduce barriers and increase facilitators associated with cancer clinical trials participation for Hispanic Americans.

Primary Outcome

To assess the impact of the intervention arm on participants' knowledge, attitudes, and perceptions related to clinical trials, they were asked to complete the same surveys given at baseline during post-intervention immediately after intervention.

Interventions

  • BEHAVIORAL Cancer Clinical Trials Education Program

Trial Details

FieldValue
Enrollment Target 1,034 participants
Start Date 2010-03
Est. Completion 2018-08
Phase Phase 3
University of California, San Diego

775 total trials

What the finished NCT02083770 record still lists

NCT02083770 is an interventional study that assigns participants to a tested intervention. Its 1,034 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (34% higher).

The record links to 0 conditions, and to 1 intervention - of which Cancer Clinical Trials Education Program is the first listed.

NCT02083770 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02083770 about?

NCT02083770 is a clinical study titled "Clinical Trials Education Program for Hispanic Americans". Hispanic Americans are underrepresented in cancer clinical trials. The purpose of this study is to develop and test programs designed to reduce barriers and increase facilitators associated with cancer clinical trials participation for Hispanic Americans.

What is the current status of trial NCT02083770?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,034 participants. The study started on 2010-03. Estimated completion is 2018-08.

What interventions are being tested in trial NCT02083770?

The interventions under investigation include: Cancer Clinical Trials Education Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02083770?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02083770's enrollment target sits among peer trials

1,034 288th of 2000 higher than 1,713 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05037682 · 1,035 participants · NA

    Pain and Opioid Management in Older Adults

  • NCT07282600 · 1,035 participants · Phase 3

    A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • NCT07084363 · 1,032 participants · NA

    Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery

  • NCT07345767 · 1,038 participants · NA

    Hypknowledge Nationwide Sleep Extension

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02083770, the US trial registry maintained by the National Library of Medicine. NCT02083770 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.